核酪穴位注射对中重度慢性阻塞性肺疾病疗效的影响

【目的】观察常规西医基础治疗联合核酪穴位注射治疗中重度慢性阻塞性肺疾病(COPD)的临床疗效。【方法】选取确诊为中度、重度COPD患者60例,随机分为治疗组和对照组各30例,治疗组给予常规西医基础治疗联合核酪双侧定喘穴穴位注射治疗,对照组单纯给予常规西医基础治疗。疗程1年。观察2组患者1年内COPD急性发作次数及住院次数,并于治疗前后采用医学研究理事会(MRC)呼吸困难分级量表评分对所有患者进行呼吸困难程度的评估。【结果】1治疗组急性发作次数及住院次数均较对照组减少,差异均有统计学意义(P0.05或P0.01);2治疗后,治疗组的MRC评分较治疗前明显改善(P0.05),而对照组改善不明显(P0.05);组间比较,治疗组改善MRC评分优于对照组,差异有统计学意义(P0.05),表明治疗组的呼吸困难程度较对照组明显改善。【结论】核酪穴位注射治疗中重度COPD的临床疗效确切。

Therapeutic Effect of Acupoint Injection with Nucleotide Plus Conventional Western Medicine Treament for Moderate and Severe Chronic Obstructive Pulmonary Disease

Objective To observe the therapeutic effect of acupoint injection with nucleotide plus conventional western medicine treatment for moderate and severe chronic obstructive pulmonary disease (COPD).Methods Sixty patients confirmed as moderate and severe COPD were evenly randomized into treatment group and control group.The treatment group was given conventional western medicine treatment and injection with nucleotide on bilateral Dingchuan points,and the control group was given conventional western medicine treatment alone.The treatment lasted for one year.The frequency of COPD acute onset and hospitalization times within one year were recorded.Meanwhile,the severity of dyspnea was evaluated with Medical Research Council (MRC) dyspnea scale scoring.Results (1)The frequency of COPD acute onset and hospitalization times within one year in the treatment group were lowered,and the differences were significant compared with those in the control group (P ＜ 0.05 or P ＜ 0.01).(2) After treatment,MRC dyspnea scale scores in the treatment group were improved (P ＜ 0.05 compared with those before treatment),but the improvement of the scores was insignificant in the control group(P ＞ 0.05).The intergroup comparison showed that the effect on improving MRC dyspnea scale scores in the treatment group was superior to that in the control group (P ＜ 0.05),indicating that the severity of dyspnea was much improved in the treatment group as compared with the control group.Conclusion Acupoint injection with nucleotide is effective on enhancing the therapeutic effect of conventional western medicine treatment for moderate and severe COPD.